The pharmaceutical company Eli Lilly will cap out-of-pocket insulin costs at $35 per month for all patients, according to NBC News. The Inflation Reduction Act previously imposed a $35 cap on insulin for Medicare beneficiaries, but Eli Lilly's new policy will automatically extend the lower price to privately insured patients as well. Uninsured patients are also eligible for the cap if they enroll in the drug company's copay assistance program.
Related Posts
Winter sports combine fun with calorie burn and strength building
Winter sports such as ice skating, snowboarding and snowshoeing are enjoying a boom, in part because they’re a perfect way to have fun and make friends….
March 16 – April 7, 2025: A traditional March event
NCAA Men’s Basketball tournament draws many fans It’s becoming one of the best-known rites of spring. The 86th annual NCAA Basketball Championship begins…
August 7 is Lighthouse Day
Lighthouses: Guiding beacons of the seas Lighthouses, with their towering structures and beaming lights, have served as guiding beacons for centuries,…